Cameroon vs Myanmar: Antiretroviral therapy coverage for PMTCT
Cameroon
59.0%
in 2024
Myanmar
54.0%
in 2024
Cameroon rank
62nd
Myanmar rank
65th
Antiretroviral therapy coverage for PMTCT over time
- Cameroon
- Myanmar
How they compare
Cameroon currently reports 59.0% against 54.0% in Myanmar, a difference of 5.0%.
That makes Cameroon's figure about 1.1 times Myanmar's.
The two have swapped places 9 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Cameroon ranks 62nd and Myanmar ranks 65th of 84 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 13.8% | 0.9% | Cameroon |
| 2010s | 79.6% | 69.7% | 9.9% | Cameroon |
| 2020s | 74.0% | 51.8% | 22.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cameroon or Myanmar?
- Cameroon, at 59.0% against 54.0% in Myanmar as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cameroon and Myanmar?
- 5.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Myanmar rank globally for antiretroviral therapy coverage for pmtct?
- Cameroon ranks 62nd and Myanmar ranks 65th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).